NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that it has engaged Integra Consulting Group LLC to provide investor relations services to the company in compliance with regulatory guidelines. According to the update, Integra leverages decades of market experience with a robust proprietary database and partners with select underexposed and undervalued emerging growth companies to continuously maximize market visibility throughout their clients’ different development cycles. Integra will work with Lexaria to provide outreach to communicate its message to maximize corporate visibility, seek out opportunities to deliver audience-targeted presentations and utilize web-casting capabilities to reach bigger audiences. Integra has assisted multiple companies with the transition from an OTC listing to a major national exchange and has the required experience to help prepare for such transitions.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer